Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount)
Achievement of the study’s primary endpoint, confirming glenzocimab’s very favorable safety profile Reduction in the number of intracerebral hemorrhages and
Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20
Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase
Paris, July 1st, 2021 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases,
Towards a new standard for device indication: Implantation for temporary or permanent use • Easy removal with a beating heart
by Jean-Alexandre Kaminisky, 2021-03-18 Karista invests in MyPL increasing its financing to €1.8m & accelerating its development Paris – France, March
Achievement of the study’s primary endpoint, confirming glenzocimab’s very favorable safety profile Reduction in the number of intracerebral hemorrhages and
Introductions : Acticor, 20 ME à lever
Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20
Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase
Latest Insights
Achievement of the study’s primary endpoint, confirming glenzocimab’s very favorable safety profile Reduction in the number of intracerebral hemorrhages and
Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20
Paris, July 17, 2018, 18h00 CET – EOS imaging (Euronext, FR0011191766 – EOSI), the pioneer of orthopedicmedical imaging 2D / 3D,
• Merck KGaA, Darmstadt, Germany’s decision to enter regulatory development with drug candidate triggers first development milestone • Candidate will
Overall demand totaling €14.7 million, 1.24 times the offering The funds raised will be used to implement the strategy of